FDA Approves Weight-management Drug Saxenda

Molecular and Cellular Pharmacology, Vol 6, No 3 (2014)

FDA Approves Weight-management Drug Saxenda

FDA News Release

Abstract

The U.S. Food and Drug Administration today approved Saxenda (liraglutide [rDNA origin] injection) as a treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity...….(click PDF to read more)

Full Text: PDF

LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041